{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T14:31:57Z","timestamp":1722609117549},"reference-count":18,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2013,8,2]],"date-time":"2013-08-02T00:00:00Z","timestamp":1375401600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"DOI":"10.1007\/s00405-013-2646-2","type":"journal-article","created":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T06:39:51Z","timestamp":1375339191000},"source":"Crossref","is-referenced-by-count":2,"title":["Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial results"],"prefix":"10.1007","author":[{"given":"Naomi","family":"van der Linden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. W. M.","family":"van Gils","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. P.","family":"Pescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Buter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Uyl-de Groot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,8,2]]},"reference":[{"key":"2646_CR1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765\u2013781","journal-title":"Eur J Cancer"},{"key":"2646_CR2","unstructured":"Nederlandse Werkgroep Hoofd-Hals Tumoren (2010) Landelijke richtlijn larynxcarcinoom, versie 3.0"},{"key":"2646_CR3","unstructured":"Nederlandse Werkgroep Hoofd-Hals Tumoren (2004) Landelijke richtlijn mondholte-en orofarynxcarcinoom, versie 1.4"},{"key":"2646_CR4","unstructured":"Nederlandse Werkgroep Hoofd-Hals Tumoren (2010) Landelijke richtlijn hypofarynxcarcinoom, versie 2.0"},{"key":"2646_CR5","unstructured":"NCCN (2012) NCCN clinical practice guidelines, head and neck cancers. http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf . Accessed 4 June 2012"},{"key":"2646_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.radonc.2011.05.036","volume":"100","author":"P Blanchard","year":"2011","unstructured":"Blanchard P, Baujat B, Holostenco V, Bourredjem A, Baey C, Bourhis J, Pignon JP, MACH-CH Collaborative Group (2011) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 100:33\u201340","journal-title":"Radiother Oncol"},{"key":"2646_CR7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","volume":"368","author":"J Bourhis","year":"2006","unstructured":"Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, Horiot JC, Le Maitre A, Pajak TF, Poulsen MG, O\u2019Sullivan B, Dobrowsky W, Hliniak A, Skladowski K, Hay JH, Pinto LH, Fallai C, Fu KK, Sylvester R, Pignon JP, Meta-Analysis of Radiotherapy in Carcinomas of Head and neck (MARCH) Collaborative Group (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368:843\u2013854","journal-title":"Lancet"},{"key":"2646_CR8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","volume":"354","author":"JA Bonner","year":"2006","unstructured":"Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Jones CU, Sur R, Raben D, Jassem J, Ove R, Kies MS, Baselga J, Youssoufian H, Amellal N, Rowinsky EK, Ang KK (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567\u2013578","journal-title":"N Engl J Med"},{"key":"2646_CR9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(09)70311-0","volume":"11","author":"JA Bonner","year":"2010","unstructured":"Bonner JA, Harari PM, Giralt J, Cohen RB, Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, Youssoufian H, Rowinsky EK, Ang KK (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21\u201328","journal-title":"Lancet Oncol"},{"key":"2646_CR10","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1200\/jco.2011.29.15_suppl.5500","volume":"29","author":"K Ang","year":"2011","unstructured":"Ang K, Zhang Q, Rosenthal D, Nguyen-Tan P, Sherman E, Weber R, Galvin J, Schwartz D, El-Naggar A, Gillison M (2011) A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). J Clin Oncol 29:5500","journal-title":"J Clin Oncol"},{"key":"2646_CR11","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/CCO.0b013e32835ff422","volume":"25","author":"JA Souza de","year":"2013","unstructured":"de Souza JA, Lopes Gde L, Cohen EE (2013) Pharmacoeconomic issues in head and neck oncology. Curr Opin Oncol 25:213\u2013217","journal-title":"Curr Opin Oncol"},{"key":"2646_CR12","unstructured":"BOM (2006) Radiotherapie gecombineerd met cetuximab bij de behandeling van lokaal vergevorderd plaveiselcelcarcinoom van het hoofd-halsgebied. Medische Oncologie\u00a0(2):52\u201354"},{"key":"2646_CR13","unstructured":"Commissie Farmaceutische Hulp (2007) Farmacotherapeutisch rapport cetuximab (Erbitux\u00ae) bij de indicatie\u00a0lokaal gevorderd plaveiselcelcarcinoom van het hoofd-halsgebied, 26094048:1\u201310"},{"key":"2646_CR14","unstructured":"Association of National Comprehensive Cancer Centres\u00a0(2011) Netherlands Cancer Registry information request K11.21"},{"issue":"12","key":"2646_CR15","first-page":"e554","volume":"13","author":"YJ Beijer","year":"2012","unstructured":"Beijer YJ, Koopman M, Terhaard CH, Braunius WW, Van Es RJ, De Graeff A (2012) Outcome and toxicity of radiotherapy combined with chemotherapy or cetuximab for head and neck cancer: our experience in one hundred and twenty-five patients. Clin Otolaryngol 13(12):e554\u2013e561","journal-title":"Clin Otolaryngol"},{"key":"2646_CR16","unstructured":"Nederlandse Werkgroep Hoofd-Halstumoren (2010) Toelichting centralisatie hoofd-hals\u00a0oncologische zorg.\u00a0Hoofd-Hals Journaal 43:6\u20139"},{"key":"2646_CR17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1758-3284-2-34","volume":"2","author":"AD Jensen","year":"2010","unstructured":"Jensen AD, Bergmann ZP, Garcia-Huttenlocher H, Freier K, Debus J, Munter MW (2010) Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience. Head Neck Oncol 2:34","journal-title":"Head Neck Oncol"},{"key":"2646_CR18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ctrv.2008.11.002","volume":"35","author":"KN Syrigos","year":"2009","unstructured":"Syrigos KN, Karachalios D, Karapanagiotou EM, Nutting CM, Manolopoulos L, Harrington KJ (2009) Head and neck cancer in the elderly: an overview on the treatment modalities. Cancer Treat Rev 35:237\u2013245","journal-title":"Cancer Treat Rev"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2646-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00405-013-2646-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-013-2646-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T07:24:25Z","timestamp":1596266665000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00405-013-2646-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,2]]},"references-count":18,"alternative-id":["2646"],"URL":"https:\/\/doi.org\/10.1007\/s00405-013-2646-2","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,2]]}}}